Pain Therapeutics/King's Remoxy "less prone to abuse" than Oxycontin
This article was originally published in Scrip
Executive Summary
Pain Therapeutics/King Pharmaceuticals' novel oxycodone controlled-release formulation, Remoxy XRT, appears to be less susceptible to abuse and misuse than Purdue Pharma's Oxycontin, a majority of FDAadvisory panel members said on November 13th.